期刊文献+

胃黏膜癌变过程中p53表达变化和幽门螺杆菌感染情况 被引量:2

Putative role of p53 expression and Hp infection in gastric carcinogenesis
下载PDF
导出
摘要 目的探讨p53表达和幽门螺旋杆菌(H.pylori,Hp)感染在慢性胃炎、胃黏膜异型增生及胃癌中的变化,分析两者的相关性及其在胃癌发生的可能关系。方法采用链霉菌抗生物素蛋白—过氧化物酶连接法(SP)免疫组化法检测p53蛋白在胃黏膜慢性炎症(40例)、胃黏膜异型增生(59例)和胃腺癌(68例)组织中的表达。采用亚甲蓝染色检测上述标本中Hp感染。分析P53表达与Hp感染的相关关系及其在胃癌发生发展中的可能意义。结果 p53在慢性炎症组中偶见个别细胞呈阳性表达(2/40,5.0%),异型增生组和胃腺癌组中p53阳性表达率分别28.8%(17/59)和51.5%(35/68),从慢性炎症组、胃黏膜异型增生到胃腺癌,呈逐渐增高趋势;Hp在慢性炎症组中的检出率为32.5%(13/40),在异型增生组和胃腺癌组中检出率分别为72.9%(43/59)和58.8%(40/68),均明显高于慢性炎症组(P<0.05)。在异型增生组和胃腺癌组,p53阳性表达率在Hp感染阳性组明显高于Hp阴性组,p53阳性表达与Hp感染均呈正相关(r=0.304、0.383,均P<0.05)。结论胃黏膜异型增生和胃腺癌组织p53表达与Hp感染密切相关,p53和Hp在胃腺癌的发生中可能发挥重要作用。 Objective To investigate p53 expression and Helicobacter pylori(H.pylori,Hp)infection in chronic gastritis,gastric dysplasia and gastric carcinoma,and to evaluate their relationship and possible role in gastric carcinogenesis.Methods The expression of p53 in the chronic gastritis(40cases),dysplasia(59cases),and gastric adenocarcinoma(68cases)were detected with streptavidin-perosidase(SP)immunohistochemical staining.Hp infection was determined with methylene blue staining.The correlation between p53 expression and Hp infection,and its possible significance in the gastric carcinogenesis were analyzed.Results The results showed that positive p53 expression was occasionally seen in individual cells in chronic gastritis(2/40,5.0%),and the positive expression rates of p53 in the dysplasia and gastric adenocarcinomas were 28.8%(17/59)and 51.5%(35/68)respectively.The expression of p53 increased from chronic gastritis,gastric dysplasia to gastric carcinoma.Hp was detected in 32.5% of chronic gastritis cases,while the detection rates reached 72.9%(43/59)and 58.8%(40/68)in dysplasia and gastric carcinoma cases,which were all significantly higher than those in chronic gastritis(P〈0.05).The p53 expression in Hp positive cases was significantly higher than that in Hp negative cases and there were positive correlations between p53 expression and Hp infection in gastric dysplasia and carcinoma cases(r=0.304、0.383,both P〈0.05).Conclusion Positive p53 expression and Hp infection exsisted in gastric dysplasia and carcinoma cases.P53 and Hp may play important roles in gastric carcinogenesis.
出处 《临床荟萃》 CAS 2015年第7期822-824,共3页 Clinical Focus
基金 山东铝业公司2014年科技计划项目(SLYF2014-3)
关键词 胃肿瘤 腺癌 免疫组织化学 肿瘤抑制蛋白质P53 幽门螺杆菌 stomach neoplasms adenocarcinoma immunohistochemistry tumor suppressor protein p53 helicobacter pylori
  • 相关文献

参考文献19

  • 1Potec T, Potec A, Sajin M, et al. Biological prognostic parameters in gastric careinomas [J]. Chirurgia, 2014, 109 (3) : 347-354.
  • 2杨占凤,林万隆,王晓燕,王允野.Hp感染与胃炎性病变,不典型增生及胃癌关系的研究[J].中国实验诊断学,2004,8(4):373-375. 被引量:10
  • 3Bhardwaj V, Noto JM, Wei J, et al. Helicobacter pylori bacteria alter the p53 stress response via ERK-HDM2 pathway [J]. Oncotarget,2015,6(3) :1531-1543.
  • 4Saf C, Gulcan EM, Ozkan F, et al. Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis[J]. Eur J Gastroenterol Hepatol, 2015,27 (2) : 155-161.
  • 5Fuccio L, Zagari RM, Eusebi LH, et al. Meta analysis: canHelicobacter pylori eradication treatment reduce the risk for gastric cancer[J].Ann Intern Med,2009,151(2) : 121-128.
  • 6Moradi M, Salehi Z, Aminian K, et al. Effects of p53 Codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population[J]. Asian Pac J Cancer Prey, 2014,15(17) : 7413-7417.
  • 7姜汉芳,姜汉国.胃癌活检组织P53、nm23和CD44v6基因蛋白表达临床意义[J].临床荟萃,2001,16(8):360-361. 被引量:2
  • 8Ochiai A, Yamauchi Y, Hirohashi S. p53 mutations in the nonneoplastic mucosa of the human stomach showing intestinal metaplasia[J]. Int J Cancer, 1996,69(1) :28-33.
  • 9Berloco P, Russo F, Cariola F, et al. Low presence of p53 abnormalities in H. pylori-infected gastric mucosa and in gastric adenocarcinoma[J]. J Gastroenterol, 2003,38 (1) : 28- 36.
  • 10Siegel R, Naishadham D, Jemal A. (2012) Cancer statistics [J]. CA Cancer J Clin, 2012, 62(1): 10-29.

二级参考文献12

  • 1何建沫,郑凯,何数.幽门螺杆菌感染引起胃癌的重要因素(附270例分析)[J].实用肿瘤杂志,1996,11(2):79-80. 被引量:8
  • 2Greenblatt MS, Bennett WP,Hollstein, et al. Mutation in the P53tumor supressor gene: clue to cancer etiology andmolecular pathogonsis. Cancer Res,1994,54(18): 4855~4878
  • 3Joypaul BV, Newan EL, Hopwood D, et al. Expression of P53 protein in normal,dysplastic, and malignant gastric mucosa: an immunohistochemical study.JPathol,1993,170(3):279~283
  • 4Helmut EG,Wolfram M, Anke S, et al. The relationship of P53 expression to theprognosis of 418 patients with gastric carcinoma. Cancer, 1995,76(5):720~726
  • 5Kodera Y, Lsobe KI, Yamauchi M, et al. Expression of nm23-H1 RNA levelsin humangastric cancer tissues. Cancer, 1994,73(2):259~265
  • 6Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confersmetastatic potential to rat carcinoma cells.Cell,1991,65(1):13~24
  • 7Heider K, Dammrich J, Skroch P, et al. Differential expression of CD44 splicevariants in intestinal and diffuse type human gastric carcinoma and normal gastric mucosa.Cancer Res, 1994,53(18):4197~4203
  • 8Dammrich J, Vollmers HP, Heider K, et al. Importance of different CD44v6 expressionin human gastric intestinal and diffuse type cancer for metastatic lymphogenic spreading.J Mol Med,1995,73(2):395~402
  • 9Wolfram M, Anke S, Karl H, et al. Expression and prognostic value ofthe CD44splicing variants V5 and V6 in gastric cancer. J Pathol,1997,183(2):222~227
  • 10魏子白,吴云林,翟祖康,王瑞年.胃癌内镜活检组织p53、c-erb-B_2和nm23蛋白检测的临床意义[J].肿瘤,1997,17(2):88-89. 被引量:5

共引文献10

同被引文献28

  • 1黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1394
  • 2所剑.谈胃癌外科治疗中的几个问题[J].中华胃肠外科杂志,2007,10(5):415-417. 被引量:2
  • 3Pliarchopoulou K, Kalogeras KT, Kronenwett R, et al. Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oneology Group trial [J]. Cancer Cbemother PharmacoI,2013,71(1) :245-255.
  • 4Liang Y, Liu M, Wang P, et al. Analysis of 20 genes at chromosome band 12q13 .. RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer [J]. Genes Chromosomes Cancer,2013,52(3) :305-315.
  • 5Milde-Langosch K, Karn T, Mtiller V, et al. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer[J]. Breast Cancer Res Treat,2013,137(1) :57-67.
  • 6Wang SM, Ooi LL, Hui KM, et al. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma[J]. Clin Cancer Res,2011,17(18) :6040-6051.
  • 7Ke HL, Ke RH, Li ST, et al. Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression [J]. J Neurooncol,2013,113(2) :327-332.
  • 8Wang F, Meng W, Wang B, et al. Helicobacter pylori- induced gastric inflammation and gastric cancer [J]. Cancer Lett, 2014,345(2): 196-202.
  • 9Wei J, Noto J, Zaika E, et al. Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses[J]. Proc Natl Acad Sci U S A,2012,109(38) :E2543-E2550.
  • 10Saigusa S, Tanaka K, Mohri Y,et al. Clinical significance of RacGAP1 expression at the invasive front of gastric cancer[J]. Gastric Cancer, 2015,18(1): 84-92.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部